MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 49 filers reported holding MONTE ROSA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,891,381 | -5.2% | 511,351 | +1.8% | 0.05% | -8.8% |
| Q3 2022 | $4,105,000 | +12.9% | 502,411 | +33.6% | 0.06% | +1.8% |
| Q2 2022 | $3,636,000 | +439.5% | 376,008 | +681.7% | 0.06% | +409.1% |
| Q1 2022 | $674,000 | -31.3% | 48,100 | +0.2% | 0.01% | -21.4% |
| Q4 2021 | $981,000 | -67.1% | 48,025 | -64.2% | 0.01% | -71.4% |
| Q3 2021 | $2,986,000 | -36.8% | 134,033 | -35.6% | 0.05% | -44.3% |
| Q2 2021 | $4,723,000 | – | 208,068 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $7,052,465 | 2.91% |
| NEA Management Company, LLC | 7,692,298 | $36,846,107 | 2.85% |
| Octagon Capital Advisors LP | 812,895 | $3,893,767 | 0.60% |
| Alphabet Inc. | 1,464,015 | $7,012,631 | 0.45% |
| Avoro Capital Advisors LLC | 4,535,000 | $21,722,650 | 0.34% |
| Casdin Capital, LLC | 510,882 | $2,447,125 | 0.27% |
| Baker Brothers Advisors | 4,916,095 | $23,548,095 | 0.14% |
| Corton Capital Inc. | 14,460 | $69,263 | 0.04% |
| ExodusPoint Capital Management, LP | 619,248 | $2,966 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 27,844 | $133,373 | 0.02% |